Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.
作者信息
RATNOFF O D, DAVIE E W, MALLETT D L
出版信息
J Clin Invest. 1961 May;40(5):803-19. doi: 10.1172/JCI104314.
Abstract
摘要
相似文献
1
Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.关于哈格曼因子作用的研究：活化的哈格曼因子反过来激活血浆促凝血酶原激酶前体的证据。
J Clin Invest. 1961 May;40(5):803-19. doi: 10.1172/JCI104314.
2
3
Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma.从人血浆中分离血浆促凝血酶原激酶前体（PTA）和哈格曼因子（HF）。
Proc Soc Exp Biol Med. 1960 Dec;105:453-5. doi: 10.3181/00379727-105-26138.
5
The contact phase of coagulation in the presence of heparin.肝素存在时凝血的接触阶段。
J Clin Pathol. 1962 Nov;15(6):508-10. doi: 10.1136/jcp.15.6.508.
6
Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent.哈格曼因子的接触激活以及哈格曼因子与血浆凝血活酶前体的相互作用。
Thromb Diath Haemorrh. 1967 May 31;17(3-4):307-20.
7
8
Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.纯化的血清C1灭活剂对活化的哈格曼因子和活化的血浆凝血活酶前体的抑制作用。
J Lab Clin Med. 1970 Nov;76(5):809-15.
9
Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).血液凝固。哈格曼因子（F-XII）和自身凝血酶原II（F-IX?）在自身凝血酶原3（F-X）激活中的作用。
Thromb Diath Haemorrh. 1970 Dec 31;24(3):345-51.
10
Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor).因子Ⅻa（活化的哈格曼因子）对人因子Ⅺ（血浆凝血活酶前体）的激活作用。
Biochemistry. 1977 Dec 27;16(26):5831-9. doi: 10.1021/bi00645a030.
引用本文的文献
1
Factor XII - What's important but not commonly thought about.凝血因子 XII——重要但常被忽视的因素。
Res Pract Thromb Haemost. 2019 Jun 19;3(4):599-606. doi: 10.1002/rth2.12235. eCollection 2019 Oct.
2
The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis.蛋白酶连接素-2的库尼茨蛋白酶抑制剂结构域可抑制因子XIa以及小鼠颈动脉和大脑中动脉血栓形成。
Blood. 2012 Jul 19;120(3):671-7. doi: 10.1182/blood-2012-03-419523. Epub 2012 Jun 6.
3
Contact activation of blood plasma and factor XII by ion-exchange resins.离子交换树脂对血浆和因子 XII 的接触激活。
Biomaterials. 2012 Jan;33(1):9-19. doi: 10.1016/j.biomaterials.2011.09.034. Epub 2011 Oct 6.
4
Hageman factor, platelets and polyphosphates: early history and recent connection. Hageman 因子、血小板和多聚磷酸盐：早期历史与近期关联。
J Thromb Haemost. 2010 Aug;8(8):1670-4. doi: 10.1111/j.1538-7836.2010.03893.x. Epub 2010 Apr 30.
5
Kinin formation and fibrinolysis in human plasma.人血浆中的激肽形成与纤维蛋白溶解
J Physiol. 1963 May;166(3):514-29. doi: 10.1113/jphysiol.1963.sp007120.
6
Observations on intrinsic kinin-forming factors in human plasma: the effect of acid, acetone, chloroform, heat and euglobulin separation on kinin formation.人血浆中内源性激肽形成因子的观察：酸、丙酮、氯仿、热和优球蛋白分离对激肽形成的影响。
J Physiol. 1963 May;166(3):496-513. doi: 10.1113/jphysiol.1963.sp007119.
7
The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide.加速素在人体血液凝固中的作用。关于加速素被活化的斯图尔特因子转化为凝血酶原转化因子的证据：兼论大豆胰蛋白酶抑制剂、硫酸鱼精蛋白和溴化己二甲铵的抗凝作用。
J Clin Invest. 1965 Feb;44(2):302-14. doi: 10.1172/JCI105144.
8
THE ACCELERATION OF THROMBUS FORMATION BY CERTAIN FATTY ACIDS.某些脂肪酸对血栓形成的加速作用。
J Clin Invest. 1962 Jun;41(6):1199-205. doi: 10.1172/JCI104580.
9
Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.活性哈格曼因子：人纤维蛋白溶解系统的一种血浆溶激酶。
J Clin Invest. 1962 Jun;41(6):1277-87. doi: 10.1172/JCI104590.
10
PATHOGENESIS OF INFLAMMATION. II. IN VIVO OBSERVATIONS OF THE INFLAMMATORY EFFECTS OF ACTIVATED HAGEMAN FACTOR AND BRADYKININ.炎症的发病机制。II. 活化的哈格曼因子和缓激肽炎症效应的体内观察。
J Exp Med. 1965 May 1;121(5):807-18. doi: 10.1084/jem.121.5.807.
本文引用的文献
1
THE CLOTTING BEHAVIOR OF HUMAN "PLATELET-FREE" PLASMA: EVIDENCE FOR THE EXISTENCE OF A "PLASMA THROMBOPLASTIN".人“无血小板”血浆的凝血行为：“血浆凝血活酶”存在的证据
J Clin Invest. 1949 Mar;28(2):340-52. doi: 10.1172/JCI102077.
2
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
3
On the role of a protein inhibitor in the first stage of blood coagulation.关于一种蛋白质抑制剂在血液凝固第一阶段中的作用。
Arch Int Physiol. 1951 Feb;58(4):386-411. doi: 10.3109/13813455109144971.
4
A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.一种与血浆中促凝成分缺乏相关的家族性出血性状。
J Clin Invest. 1955 Apr;34(4):602-13. doi: 10.1172/JCI103109.
5
Inactivation of Hageman factor by diisopropylfluorophosphate (DFP).二异丙基氟磷酸酯（DFP）对凝血因子Ⅻ的灭活作用。
J Lab Clin Med. 1960 Jul;56:136-8.
6
Deficiency of one or more factors of unusual interest.一种或多种特别感兴趣的因子缺乏。
Thromb Diath Haemorrh. 1960;4(Suppl):151-7.
7
Experiments on Hageman factor.关于哈格曼因子的实验。
Thromb Diath Haemorrh. 1960;4(Suppl):132-6.
8
Hageman trait.哈格曼特性
Thromb Diath Haemorrh. 1960;4(Suppl):116-22.
9
The role of Hageman factor in the initiation of blood coagulation.哈格曼因子在血液凝固起始过程中的作用。
Br J Haematol. 1959 Apr;5(2):203-11. doi: 10.1111/j.1365-2141.1959.tb04026.x.
10
Hageman trait and PTA deficiency; the role of contact of blood with glass.哈格曼特性与血浆凝血活酶前体缺乏症；血液与玻璃接触的作用。
Br J Haematol. 1959 Jan;5(1):121-38. doi: 10.1111/j.1365-2141.1959.tb04017.x.
Zotero 插件